PetMed Express Inc. (NASDAQ:PETS) CEO Menderes Akdag sold 10,000 shares of the business’s stock in a transaction on Monday, October 10th. The shares were sold at an average price of $21.00, for a total transaction of $210,000.00. Following the completion of the transaction, the chief executive officer now directly owns 600,000 shares of the company’s stock, valued at approximately $12,600,000. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Menderes Akdag also recently made the following trade(s):
- On Thursday, September 22nd, Menderes Akdag sold 10,000 shares of PetMed Express stock. The shares were sold at an average price of $20.75, for a total transaction of $207,500.00.
PetMed Express Inc. (NASDAQ:PETS) opened at 20.49 on Friday. The firm has a market capitalization of $413.49 million, a price-to-earnings ratio of 19.51 and a beta of 1.07. The company has a 50-day moving average of $20.42 and a 200-day moving average of $19.30. PetMed Express Inc. has a 52 week low of $15.61 and a 52 week high of $21.16.
PetMed Express (NASDAQ:PETS) last released its quarterly earnings results on Monday, July 25th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.31 by $0.01. The firm earned $72.50 million during the quarter. PetMed Express had a net margin of 9.09% and a return on equity of 25.97%. PetMed Express’s revenue was up 1.3% on a year-over-year basis. During the same period in the previous year, the business posted $0.29 EPS. On average, equities analysts forecast that PetMed Express Inc. will post $1.11 earnings per share for the current fiscal year.
Several institutional investors have recently added to or reduced their stakes in the stock. Bank of Montreal Can acquired a new position in PetMed Express during the second quarter valued at about $143,000. Acadian Asset Management LLC purchased a new position in shares of PetMed Express during the second quarter worth $1,483,000. Cutler Group LP increased its position in shares of PetMed Express by 832.0% in the second quarter. Cutler Group LP now owns 7,064 shares of the company’s stock worth $132,000 after buying an additional 8,029 shares in the last quarter. North Star Investment Management Corp. increased its position in shares of PetMed Express by 1.5% in the second quarter. North Star Investment Management Corp. now owns 126,178 shares of the company’s stock worth $2,367,000 after buying an additional 1,903 shares in the last quarter. Finally, NEXT Financial Group Inc increased its position in shares of PetMed Express by 167.2% in the second quarter. NEXT Financial Group Inc now owns 5,354 shares of the company’s stock worth $100,000 after buying an additional 3,350 shares in the last quarter. 75.97% of the stock is owned by hedge funds and other institutional investors.
Several equities analysts have recently issued reports on PETS shares. Zacks Investment Research lowered shares of PetMed Express from a “buy” rating to a “hold” rating in a report on Tuesday, September 27th. Credit Suisse Group AG reaffirmed a “sell” rating and issued a $13.00 target price on shares of PetMed Express in a research note on Tuesday, August 16th.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.